RETHYMIC Trademark

Trademark Overview


On Thursday, December 5, 2019, a trademark application was filed for RETHYMIC with the United States Patent and Trademark Office. The USPTO has given the RETHYMIC trademark a serial number of 88715931. The federal status of this trademark filing is REGISTERED as of Tuesday, March 23, 2021. This trademark is owned by Enzyvant Therapeutics GmbH. The RETHYMIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto
rethymic

General Information


Serial Number88715931
Word MarkRETHYMIC
Filing DateThursday, December 5, 2019
Status700 - REGISTERED
Status DateTuesday, March 23, 2021
Registration Number6298011
Registration DateTuesday, March 23, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 5, 2021

Trademark Statements


Indication of Colors claimedThe color(s) blue, yellow, turquoise, and dark turquoise is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the dark turquoise wording "RETHYMIC" to the right of a turquoise circular design wherein the circle has a curved slice removed from it and the circle has a blue dot at the bottom and a yellow area behind the blue dot.
Goods and ServicesPharmaceutical preparations for human use for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 10, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEnzyvant Therapeutics GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Party NameEnzyvant Therapeutics GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4051
CH

Party NameEnzyvant Therapeutics GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Trademark Events


Event DateEvent Description
Tuesday, March 23, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, January 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 2, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 1, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 30, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 30, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, June 10, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, June 10, 2020FINAL REFUSAL E-MAILED
Wednesday, June 10, 2020FINAL REFUSAL WRITTEN
Thursday, June 4, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 3, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 9, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 9, 2020NON-FINAL ACTION E-MAILED
Monday, March 9, 2020NON-FINAL ACTION WRITTEN
Friday, March 6, 2020ASSIGNED TO EXAMINER
Thursday, January 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 9, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 7, 2020ASSIGNED TO LIE
Monday, December 16, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, December 11, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 9, 2019NEW APPLICATION ENTERED IN TRAM